CROs/Service Providers

WCG, PCCTC partner to improve oncology research reviews

Tuesday, September 29, 2015

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a multicenter clinical research organization specializing in cutting-edge prostate cancer research, have formed a new partnership to enhance the quality and efficiency of the consortium’s research review process.

[Read More]

WuXi NextCODE partners with hospital

Friday, September 25, 2015

WuXi NextCODE, a precision medicine company using the genome to improve health worldwide, and the Children’s Hospital of Fudan University (CHFU), based in Shanghai, have partnered to advance precision medicine in China. It brings WuXi NextCODE’s genomic testing capabilities directly into clinical use for the first time in China, and builds on CHFU’s preeminence in pediatrics to immediately begin delivering benefits to thousands of rare disease patients across China.

[Read More]

Venn Life Sciences to acquire Kinesis

Friday, September 25, 2015

Venn Life Sciences, a European CRO, has entered into an agreement to acquire the entire issued share capital of Kinesis Pharma, a Netherlands-based provider of specialist consultancy services around the chemical-pharmaceutical, nonclinical and early clinical development of drug products, for a total maximum consideration of up to $7.3 million (€6.5 million).

[Read More]

ShangPharma, Qidong Biopharma ink agreement

Friday, September 25, 2015

ShangPharma has planned to establish a subsidiary in the Qidong Biopharma Industrial Zone as part of a multistage expansion project for its biologics service portfolio. In the first phase, ShangPharma and Qidong Biopharma Industrial Zone will invest $60 million to build a comprehensive and multifunctional preclinical research facility as well as a state-of-the-art biologics manufacturing facility.

[Read More]

BioClinica acquires Synowledge

Wednesday, September 23, 2015

BioClinica, a specialty clinical trials services and technology provider, has acquired Synowledge to expand its offering into the growing drug safety and regulatory business process outsourcing market. Based in Miami, Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies with recording, analyzing and reporting adverse drug events.

[Read More]